16 Programs

  • Consensus or Controversy? Clinical Investigators Discuss and Debate Current Approaches to First- and Second-Line Therapy for HR-Positive Metastatic Breast Cancer

    Explore program
  • What Clinicians Want to Know: First-Line and Maintenance Therapy for Patients with ER-Positive HER2-Positive Metastatic Breast Cancer

    Explore program
    • April 2026 1.25 ABIM MOC, ABS MOC, CME 57min
      • I
        Ian E Krop, MD, PhD
      • V
      Dr Krop, Dr Borges
  • Practical Perspectives on the Current and Future Management of Immune Thrombocytopenia — What Happened at ASH 2025?

    Explore program
  • Diabetology for the Medical Oncologist: Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway

    Explore program
    • March 2026 1.5 ABIM MOC, ABS MOC, CME 1h 15min
      • H
        Hope S Rugo, MD
      • J
      • M
      • +1
      Dr Rugo, J Carroll, Dr McDonnell, Dr Curigliano